The cannabis-based multiple sclerosis drug Sativex has been recommended for use in Wales, making it the first in the United Kingdom to do so. The drug awaits final approval from the government.
A novel gene has been identified as having a regulatory role in nerve conduction velocity, according to an experimental study published online Aug. 12 in The Journal of Pathology.
The autoimmune system may not be the primary location for multiple sclerosis development, according to a study published in Science Translational Medicine.
A new technique could aid patients recovering from spinal cord injuries and disorders affecting spinal cord function, according to researchers at Vanderbilt University.
HIV infection is associated with a significantly decreased risk of developing multiple sclerosis, according to a study published online August 4 in the Journal of Neurology, Neurosurgery & Psychiatry.
A team of researchers has pinpointed a small molecule responsible for nerve cell damage and other symptoms tied to neurological diseases, including multiple sclerosis (MS).